Compare
Abbott Laboratories vs Becton Dickinson (ABT vs BDX)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Becton Dickinson (BDX) +52.8%; so far this year the figures are -12.3% and +38.9%.
Abbott Laboratories is the larger company by market value, about 3.3 times the size of Becton Dickinson.
On trailing earnings, ABT trades at 40.9 times and BDX at 63.8 times.
Revenue grew +10.0% at ABT and +17.4% at BDX over the last year.
ABT yields 2.29%. BDX yields 1.88%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | BDX | |
|---|---|---|
| Price | $109.93 | $211.88 |
| 1-day | -3.23% | -0.78% |
| YTD | -12.26% | +38.87% |
| 1 year | -11.73% | +52.79% |
| 3 years | +15.70% | +6.20% |
| Market cap | $190.4B | $57.7B |
| P/E | 40.9 | 63.8 |
| P/S | 3.95 | 2.48 |
| P/B | 3.73 | 2.36 |
| Revenue growth | +10.00% | +17.40% |
| EPS growth | -66.20% | -39.40% |
| Gross margin % | 56.9 | 46.9 |
| Net margin % | 9.7 | 4.0 |
| ROE % | 9.2 | 3.9 |
| Debt / equity | 0.61 | 0.69 |
| FCF yield % | 3.5 | 4.6 |
| Dividend yield % | 2.29 | 1.88 |
| Beta | 0.06 | 0.25 |
| RSI (14) | 58.5 | 74.6 |
| Technical rating |